- Home
- KRMD vs SSSS Comparison
KRMD vs SSSS Comparison
Compare KRMD & SSSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRMD
- SSSS
- Stock Information
- Founded
- KRMD 1980
- SSSS 2010
- Country
- KRMD United States
- SSSS United States
- Employees
- KRMD N/A
- SSSS N/A
- Industry
- KRMD Medical/Dental Instruments
- SSSS Finance: Consumer Services
- Sector
- KRMD Health Care
- SSSS Finance
- Exchange
- KRMD Nasdaq
- SSSS Nasdaq
- Market Cap
- KRMD 134.3M
- SSSS 138.2M
- IPO Year
- KRMD N/A
- SSSS N/A
- Fundamental
- Price
- KRMD $2.79
- SSSS $6.31
- Analyst Decision
- KRMD Strong Buy
- SSSS Buy
- Analyst Count
- KRMD 4
- SSSS 2
- Target Price
- KRMD $4.63
- SSSS $8.00
- AVG Volume (30 Days)
- KRMD 131.4K
- SSSS 195.6K
- Earning Date
- KRMD 05-07-2025
- SSSS 05-06-2025
- Dividend Yield
- KRMD N/A
- SSSS N/A
- EPS Growth
- KRMD N/A
- SSSS N/A
- EPS
- KRMD N/A
- SSSS N/A
- Revenue
- KRMD $35,083,740.00
- SSSS $3,644,430.00
- Revenue This Year
- KRMD $18.16
- SSSS $6.95
- Revenue Next Year
- KRMD $14.60
- SSSS N/A
- P/E Ratio
- KRMD N/A
- SSSS N/A
- Revenue Growth
- KRMD 19.65
- SSSS N/A
- 52 Week Low
- KRMD $1.86
- SSSS $3.52
- 52 Week High
- KRMD $5.05
- SSSS $6.83
- Technical
- Relative Strength Index (RSI)
- KRMD 48.68
- SSSS 64.88
- Support Level
- KRMD $2.63
- SSSS $6.16
- Resistance Level
- KRMD $2.97
- SSSS $6.77
- Average True Range (ATR)
- KRMD 0.19
- SSSS 0.34
- MACD
- KRMD -0.03
- SSSS 0.02
- Stochastic Oscillator
- KRMD 24.44
- SSSS 60.00
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
About SSSS SuRo Capital Corp.
SuRo Capital Corp is a non-diversified closed-end management investment company. The company's investment objective is to maximize its portfolio's total return, principally by seeking capital gains on its equity and equity-related investments.